BAYRY:OTC-Bayer Aktiengesellschaft (USD)

COMMON STOCK | Drug Manufacturers-General | OTC

Last Closing Price

USD 14.20

Change

0.00 (0.00)%

Market Cap

USD 55.78B

Volume

0.30M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc. and Forschungszentrum Jülich GmbH; strategic research partnership with University of Oxford to develop novel gynecological therapies; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-27 )

Largest Industry Peers for Drug Manufacturers-General

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHHBF Roche Holding AG

-9.81 (-2.26%)

USD348.74B 24.47 15.15
RHHVF Roche Holding AG

-6.08 (-1.55%)

USD340.29B 22.07 15.15
RHHBY Roche Holding AG

-0.49 (-1.01%)

USD339.60B 21.91 15.15
AZNCF AstraZeneca PLC

-0.32 (-0.26%)

USD190.75B 42.89 23.06
NVSEF Novartis AG

-2.24 (-2.63%)

USD190.32B 21.56 12.03
SNYNF Sanofi

N/A

USD126.84B 18.65 12.40
GLAXF GlaxoSmithKline plc

+0.34 (+1.75%)

USD97.92B 16.28 12.13
CHGCF Chugai Pharmaceutical Co. Ltd

N/A

USD61.40B 25.16 0.16
CHGCY Chugai Pharmaceutical Co. Ltd

+0.01 (+0.05%)

USD61.28B 27.19 0.16
BAYZF Bayer Aktiengesellschaft

-0.06 (-0.11%)

USD55.69B 8.75 12.62

ETFs Containing BAYRY

Symbol Name Weight Mer Price(Change) Market Cap
DBGR Xtrackers MSCI Germany He.. 0.00 % 0.45 %

-0.14 (-0.42%)

USD0.01B
C003:XETRA Lyxor DivDAX (DR) UCITS E.. 0.00 % 0.25 %

-0.05 (-0.14%)

USD0.07B
EL4F:XETRA Deka DAX (ausschüttend) .. 0.00 % 0.15 %

-0.26 (-0.39%)

USD0.06B
EL4A:XETRA Deka DAX UCITS ETF 0.00 % 0.00 %

-0.54 (-0.38%)

USD0.01B
EESM:XETRA BNP Paribas Easy - MSCI E.. 0.00 % 0.00 %

-0.10 (-0.03%)

USD0.08B
E903:XETRA Lyxor 1 - DivDAX UCITS ET.. 0.00 % 0.25 %

-0.28 (-0.15%)

USD0.04B
E901:XETRA Lyxor 1 DAX UCITS ETF (I) 0.00 % 0.15 %

N/A

USD0.11B
DBXD:XETRA Xtrackers - DAX UCITS ETF 0.00 % 0.09 %

-0.60 (-0.40%)

USD4.28B
CEUG:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.95 (-0.33%)

USD2.32B
C068:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.08B
C006:XETRA Lyxor F.A.Z. 100 Index (D.. 0.00 % 0.15 %

-0.17 (-0.52%)

USD0.09B
C002:XETRA ComStage - FR DAX UCITS E.. 0.00 % 0.15 %

N/A

USD0.05B
EXSB:XETRA iShares DivDAX UCITS ETF .. 0.00 % 0.31 %

-0.02 (-0.11%)

USD2,635.27B
C001:XETRA Lyxor Core DAX (DR) UCITS.. 0.00 % 0.08 %

-0.50 (-0.37%)

USD0.95B
XDDX:F Xtrackers - DAX Income UC.. 0.00 % 0.09 %

-0.46 (-0.38%)

USD0.54B
WTEZ:F WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

N/A
WTEE:F WisdomTree Europe Equity .. 0.00 % 0.29 %

-0.03 (-0.24%)

USD0.02B
VX5E:F Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

USD0.04B
SPYW:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.30 %

+0.08 (+0.33%)

USD1.52B
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

-0.26 (-0.14%)

USD0.72B
LYY7:F Multi Units Luxembourg - .. 0.00 % 0.15 %

-0.48 (-0.33%)

USD0.68B
IQQV:F iShares Euro Total Market.. 0.00 % 0.40 %

N/A

USD0.03B
EXV4:F iShares (DE) I - iShares .. 0.00 % 0.46 %

-0.10 (-0.10%)

USD0.44B
ELF0:XETRA Deka DAX ex Financials 30.. 0.00 % 0.30 %

-0.10 (-0.33%)

USD0.43B
EXV4:XETRA iShares (DE) I - iShares .. 0.00 % 0.46 %

-0.84 (-0.81%)

USD0.44B
ELF0:F Deka DAX ex Financials 30.. 0.00 % 0.30 %

-0.06 (-0.20%)

USD0.43B
EXS1:XETRA iShares Core DAX UCITS ET.. 0.00 % 0.16 %

-0.50 (-0.37%)

USD5,933.93B
ESIH:LSE Ishares VI PLC - Ishares .. 0.00 % 0.00 %

+0.02 (+0.36%)

N/A
VGER:F Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

N/A
E909:F Lyxor 1 DAX® 50 ESG UCIT.. 0.00 % 0.00 %

N/A

N/A
JPHU:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JPHG:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
VGER:XETRA Vanguard Germany All Cap .. 0.00 % 0.00 %

-0.11 (-0.39%)

USD0.10B
ELFG:XETRA Deka Germany 30 UCITS ETF 0.00 % 0.00 %

-6.60 (-0.39%)

USD0.52B
E909:XETRA Lyxor 1 DAX® 50 ESG UCIT.. 0.00 % 0.05 %

-0.13 (-0.33%)

USD0.21B
AMEC:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.88 (-1.38%)

USD0.08B
ZGEN:CA BMO MSCI Genomic Innovati.. 0.00 % 0.00 %

-0.48 (-1.63%)

N/A
XDDX:XETRA Xtrackers - DAX Income UC.. 0.00 % 0.09 %

-0.46 (-0.38%)

USD0.54B
FRCA:XETRA UBS ETF - MSCI EMU hedged.. 0.00 % 0.28 %

N/A

USD0.35B
X503:XETRA ComStage - iBOXX Euro Liq.. 0.00 % 0.12 %

N/A

USD5.98M
WTEZ:XETRA WisdomTree Germany Equity.. 0.00 % 0.32 %

N/A

N/A
WTEE:XETRA WisdomTree Europe Equity .. 0.00 % 0.29 %

-0.03 (-0.29%)

USD0.02B
VX5E:XETRA Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

USD0.04B
VDXX:XETRA Vanguard Funds Public Lim.. 0.00 % 0.00 %

N/A

USD0.12B
SPYH:XETRA SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

-1.42 (-0.76%)

USD0.72B
MIVU:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.60 (-0.82%)

USD0.14B
LYY7:XETRA Multi Units Luxembourg - .. 0.00 % 0.15 %

-0.56 (-0.38%)

USD0.68B
IQQV:XETRA iShares Euro Total Market.. 0.00 % 0.40 %

N/A

USD0.03B
GOAI:XETRA Amundi Stoxx Global Artif.. 0.00 % 0.00 %

-0.99 (-1.16%)

USD0.19B
EXSB:F iShares DivDAX UCITS ETF .. 0.00 % 0.31 %

-0.05 (-0.27%)

USD2,635.27B
EL4F:F Deka DAX (ausschüttend) .. 0.00 % 0.15 %

-0.12 (-0.18%)

USD0.06B
DXGE WisdomTree Germany Hedged.. 0.00 % 0.58 %

-0.01 (-0.03%)

USD0.03B
DXGP:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.35 %

N/A

N/A
S6EW:LSE Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.00 %

N/A

USD0.32B
L6EW:LSE Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.35 %

N/A

USD0.32B
IDJV:LSE iShares Euro Total Market.. 0.00 % 0.40 %

N/A

USD0.03B
HLTH:LSE SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

-1.17 (-0.63%)

USD0.71B
EEIP:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

+0.30 (+0.02%)

USD3.94M
EEIE:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

N/A

USD0.02B
EEIA:LSE WisdomTree Europe Equity .. 0.00 % 0.29 %

N/A

USD3.94M
EEI:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

+2.80 (+0.28%)

USD0.02B
DXGZ:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

N/A
DXGY:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.32 %

N/A

N/A
DXGG:LSE WisdomTree Germany Equity.. 0.00 % 0.48 %

N/A

N/A
UC89:LSE UBS ETF - MSCI EMU hedged.. 0.00 % 0.28 %

N/A

USD0.35B
DXGE:LSE WisdomTree Germany Equity.. 0.00 % 0.48 %

N/A

N/A
CEUR:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

+122.84 (+0.51%)

USD2.56B
ZDEU SPDR Solactive Germany ET.. 0.00 % 0.14 %

N/A

USD0.03B
FLGR Franklin FTSE Germany ETF 0.00 % 0.09 %

-0.10 (-0.39%)

USD0.01B
ZVI:CA BMO MSCI EAFE Value Index.. 0.00 % 0.40 %

N/A

USD3.93M
MOO VanEck Vectors Agribusine.. 0.00 % 0.55 %

-1.02 (-1.07%)

USD1.18B
IVLU iShares Edge MSCI Intl Va.. 0.00 % 0.30 %

-0.20 (-0.76%)

USD1.13B
HEWG iShares Trust - iShares C.. 0.00 % 0.53 %

-0.17 (-0.51%)

USD0.06B
FTAG First Trust Exchange-Trad.. 0.00 % 0.70 %

N/A

USD5.66M
EWG iShares MSCI Germany ETF 0.00 % 0.51 %

-0.15 (-0.44%)

USD3.02B
JPNY:LSE Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD9.14B
XCS5:LSE Xtrackers - MSCI India Sw.. 0.00 % 0.75 %

-0.14 (-0.79%)

N/A
EL4A:F Deka DAX UCITS ETF 0.00 % 0.00 %

-0.14 (-0.10%)

USD0.01B
C001:F Lyxor Core DAX® (DR) UCI.. 0.00 % 0.08 %

-0.70 (-0.52%)

USD0.95B
E903:F Lyxor 1 - DivDAX UCITS ET.. 0.00 % 0.25 %

-0.58 (-0.31%)

USD0.04B
E901:F Lyxor 1 DAX UCITS ETF (I) 0.00 % 0.15 %

N/A

USD0.10B
DBXD:F Xtrackers - DAX UCITS ETF 0.00 % 0.09 %

-0.14 (-0.09%)

USD4.28B
DBPD:F Xtrackers - ShortDAX x2 D.. 0.00 % 0.60 %

+0.01 (+0.51%)

USD0.13B
D5BL:F Xtrackers - MSCI Europe V.. 0.00 % 0.25 %

-0.12 (-0.46%)

USD0.02B
CEMS:F iShares IV Public Limited.. 0.00 % 0.25 %

-0.03 (-0.44%)

USD3.00B
C068:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.08B
C006:F Lyxor F.A.Z. 100 Index (D.. 0.00 % 0.15 %

-0.31 (-0.97%)

USD0.09B
C003:F Lyxor DivDAX® (DR) UCITS.. 0.00 % 0.25 %

-0.22 (-0.65%)

USD0.07B
C002:F ComStage FR DAX UCITS ETF 0.00 % 0.15 %

N/A

USD0.05B
STW:PA SSgA SPDR ETFs Europe II .. 0.00 % 0.23 %

-1.34 (-0.72%)

USD0.72B
XCX5:LSE Xtrackers - MSCI India Sw.. 0.00 % 0.00 %

+1.50 (+0.12%)

USD0.10B
MIVU:PA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.59 (-0.81%)

USD0.14B
EUDV:PA SSgA SPDR ETFs Europe I P.. 0.00 % 0.30 %

+0.04 (+0.17%)

USD1.56B
EESM:PA BNP Paribas Easy MSCI Eur.. 0.00 % 0.00 %

-0.27 (-0.08%)

USD0.08B
DAX:PA Multi Units Luxembourg - .. 0.00 % 0.15 %

-0.54 (-0.37%)

USD0.67B
CG1:PA Amundi ETF DAX UCITS ETF .. 0.00 % 0.00 %

-0.95 (-0.33%)

USD0.25B
VX5E:LSE Vanguard Euro STOXX 50 UC.. 0.00 % 0.00 %

N/A

USD0.04B
VDXX:LSE Vanguard Germany All Cap .. 0.00 % 0.00 %

N/A

USD0.04B
XSPS:LSE Xtrackers - S&P 500 Inver.. 0.00 % 0.50 %

+4.70 (+0.84%)

USD0.28B
XSPD:LSE Xtrackers - S&P 500 Inver.. 0.00 % 0.50 %

+0.03 (+0.43%)

USD0.28B
XLDX:LSE Xtrackers - LevDAX Daily .. 0.00 % 0.35 %

-78.00 (-0.60%)

USD0.05B
ESIH:XETRA iShares MSCI Europe Healt.. 0.00 % 0.18 %

-0.04 (-0.68%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-General)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.35% 43% F 38% F
Dividend Return 4.00% 85% B 60% D-
Total Return -0.35% 47% F 40% F
Trailing 12 Months  
Capital Gain 19.39% 73% C 46% F
Dividend Return 4.99% 90% A- 61% D-
Total Return 24.38% 82% B- 48% F
Trailing 5 Years  
Capital Gain -42.77% 8% F 28% F
Dividend Return 13.85% 75% C 46% F
Total Return -28.92% 8% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -12.91% 11% F 8% F
Dividend Return 3.22% 67% D+ 61% D-
Total Return -9.69% 11% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 21.23% 55% F 79% C+
Risk Adjusted Return -45.62% 11% F 8% F
Market Capitalization 55.78B 76% C 98% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-General)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.67 95% A 69% D+
Price/Book Ratio 1.57 79% C+ 53% F
Price / Cash Flow Ratio 11.38 45% F 18% F
EV/EBITDA 12.62 30% F 27% F
Management Effectiveness  
Return on Equity -22.75% 5% F 25% F
Return on Invested Capital 1.25% 11% F 47% F
Return on Assets 3.53% 21% F 73% C
Debt to Equity Ratio 105.71% 30% F 17% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.31 3% F 32% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector